What changed in this filing

/stocks — the workspaceLOADING

Item 2. Management’s Discussion and Analysis

2022-05-13 compared with 2021-11-15 · 343 added, 259 removed, 26 unchanged (96% of the section changed)

Management’s Discussion and Analysis of Financial

Condition and Results of Operations.

Management’s Discussion and

Analysis of Financial Condition and Results of Operations.

References to the “Company,” “Inflection

Point Acquisition Corp.,” “our,” “us” or “we” refer to Inflection Point Acquisition Corp.

following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with

the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report on Form 10-Q.

Cautionary Note Regarding Forward-Looking Statements

following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction

with the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report on Form

Cautionary Note Regarding Forward-Looking

This Quarterly Report on Form 10-Q includes forward-looking

2 unchanged sentences

There can be no assurance that future developments affecting us will be those that we have anticipated.

forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may

cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.

forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes,

beliefs, intentions or strategies regarding the future.

In addition, any statements that refer to projections, forecasts or other characterizations

of future events or circumstances, including any underlying assumptions, are forward-looking statements.

The words “anticipate,”

“believe,” “continue,” “could,” “estimate,” “expect,” “intends,”

“may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,”

“should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words

does not mean that a statement is not forward-looking.

Factors that might cause or contribute to such forward-looking statements include,

but are not limited to, those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the

Company’s offering filed with the SEC.

The following discussion and analysis of the Company’s financial condition and results

of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained

elsewhere in this Quarterly Report on Form 10-Q.

We are a blank check company incorporated on January

27, 2021 as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition,

share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).

Our sponsor is Inflection Point Holdings LLC,

a Cayman Islands limited liability company (the “Sponsor”).

The registration statement for our initial public offering was

declared effective on September 21, 2021.

On September 24, 2021, we consummated our initial public offering (the “IPO”) of

30,000,000 units , at $10.00 per unit (the “Units”) .

Each Unit consists of the

Company’s Class A ordinary shares, $0.0001 par value (the “Class A ordinary shares” or “Public Shares”)

forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that

may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.

Our forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations,

hopes, beliefs, intentions or strategies regarding the future.

In addition, any statements that refer to projections, forecasts or other

characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements.

“anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,”

“intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,”

“project,” “should,” “would” and similar expressions may identify forward-looking statements, but

the absence of these words does not mean that a statement is not forward-looking.

Factors that might cause or contribute to such forward-looking

statements include, but are not limited to, those set forth in the Risk Factors section of the Company’s Annual Report on Form

10-K for the year ended December 31, 2021 filed with the SEC.

The following discussion and analysis of the Company’s financial

condition and results of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes

thereto contained elsewhere in this Quarterly Report on Form 10-Q.

We are a blank check

company incorporated on January 27, 2021 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange,

asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “ Business

Combination ”).

Our sponsor is Inflection

Point Holdings LLC, a Cayman Islands limited liability company (the “ Sponsor ”).

The registration statement for our

initial public offering was declared effective on September 21, 2021.

On September 24, 2021, we consummated our initial public offering

(the “ IPO ”) of 30,000,000 units, at $10.00 per unit (the “ Units ”).

Each Unit consists of one of

our Class A ordinary shares, $0.0001 par value (the “ Class A ordinary shares ” or “ Public Shares ”)

and one-half of one redeemable warrant (each, a “ Public Warrant ”).

The underwriters had a 45-day option from the Effective

Date to purchase up to an additional 4,500,000 Units to cover over-allotments, if any.

On October 29, 2021, the underwriters partially

exercised the over-allotment option (the “Over-Allotment” and together with the IPO, the “Public Offering”) and

purchased an additional 2,975,000 Units (the “Over-Allotment Units”), generating additional gross proceeds of $29,750,000,

and forfeited their option to purchase the remaining 1,525,000 Units.

Simultaneously with the closing of the IPO, the

Sponsor purchased an aggregate of 6,250,000 private placement warrants (“IPO Private Placement Warrants”) at a price of $1.00

per IPO Private Placement Warrants, for an aggregate purchase price of $6,250,000.

On October 29, 2021, simultaneously with the sale of

the Over-Allotment Units, the Sponsor purchased an additional 595,000 private placement warrants (the “Over-Allotment Private Placement

Warrants” and together with the IPO Private Placement Warrants, the “Private Placement Warrants”), generating aggregate

gross proceeds to the Company of $595,000.

An aggregate of 12 qualified institutional buyers

(“Anchor Investors”) expressed an interest to purchase an aggregate of approximately $322.3 million of the Units sold in the

None of the Anchor Investors expressed an interest in purchasing more than 9.9% of the Units sold in the IPO.

The Anchor Investors

were allocated and purchased a total of 29,540,000 Units or 98.5% of the Units sold in the IPO.

One of the Anchor Investors, Kingstown

1740 Fund, LP, is an affiliate of the Sponsor, and was allocated and purchased 2,900,000 Units sold in the IPO.

In addition, subject to each Anchor Investor purchasing

100% of the Units allocated to it, in connection with the closing of the IPO, the Sponsor sold membership interests reflecting an allocation

of Class B ordinary shares, par value $0.0001 per share (the “Founder Shares”) to each Anchor Investor, or an aggregate of

1,625,000 Founder Shares to all Anchor Investors.

The Company estimated the aggregate fair value of these Founder Shares attributable

to Anchor Investors to be approximately $9.68 million, or $5.96 per share.

The excess of the fair value of the Founder Shares was determined

to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A.

Offering costs allocated to the Public Shares and the Public

Warrants was all charged to shareholder’s equity upon the completion of the IPO.

As of September 30, 2021, transaction costs amounted

to $15,271,938 consisting of $4,000,000 of underwriting commissions, $10,500,000 of deferred underwriting commissions, and $771,938 of

other offering costs, and was all charged to shareholders’ equity.

In connection with the sale of the Over-Allotment Units on October

29, 2021, the Company incurred additional transactions costs amounting to $1,636,250 consisting of $595,000 of underwriting commissions

and $1,041,250 of deferred underwriting commissions.

Following the closing of the IPO on September

24, 2021, $300,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement

Warrants was deposited into a trust account (the “Trust Account”).

Following the closing of the Over-Allotment on October

29, 2021, an additional $29,750,000 ($10.00 per Over-Allotment Unit) from the net proceeds from the sale of the Over-Allotment Units in

the Over-Allotment and the sale of the Over-Allotment Private Placement Units was deposited into the Trust Account.

The proceeds deposited

in the Trust Account will be invested only in U.S.

government securities, within the meaning set forth in Section 2(a)(16) of the Investment

Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under

the Investment Company Act which invest only in direct U.S.

The underwriters had a 45-day option from

the effective date to purchase up to an additional 4,500,000 Units to cover over-allotments, if any.

On October 29, 2021, the underwriters

partially exercised the over-allotment option (the “ Over-Allotment ” and together with the IPO, the “ Public

Offering ”) and purchased an additional 2,975,000 Units (the “ Over-Allotment Units ”), generating additional

gross proceeds of $29,750,000, and forfeited their option to purchase the remaining 1,525,000 Units.

Simultaneously with

the closing of the IPO, our Sponsor purchased an aggregate of 6,250,000 private placement warrants (“ IPO Private Placement Warrants ”)

at a price of $1.00 per IPO Private Placement Warrants, for an aggregate purchase price of $6,250,000.

On October 29, 2021, simultaneously

with the sale of the Over-Allotment Units, our Sponsor purchased an additional 595,000 private placement warrants (the “ Over-Allotment

Private Placement Warrants ” and together with the IPO Private Placement Warrants, the “ Private Placement Warrants ”),

generating aggregate gross proceeds to us of $595,000.

An aggregate of 12 qualified

institutional buyers (“ Anchor Investors ”) expressed an interest to purchase an aggregate of approximately $322.3 million

of the Units to be sold in the IPO.

None of the Anchor Investors expressed an interest in purchasing more than 9.9% of the Units sold

The Anchor Investors were allocated and purchased a total of 29,540,000 Units or 98.5% of the Units sold in the IPO.

of the Anchor Investors, Kingstown 1740 Fund, LP, is an affiliate of our Sponsor, and was allocated and purchased 2,900,000 Units in

In addition, subject

to each Anchor Investor purchasing 100% of the Units allocated to it, in connection with the closing of the IPO, our Sponsor sold membership

interests reflecting an allocation of Class B ordinary shares, par value $0.0001 per share (the “ Founder Shares ”)

to each Anchor Investor, or an aggregate of 1,625,000 Founder Shares to all Anchor Investors.

We estimated the aggregate fair value of

these Founder Shares attributable to Anchor Investors to be approximately $9.68 million, or $5.96 per share.

The excess of the fair value

of the Founder Shares was determined to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A.

Offering costs allocated

to the Public Shares and the Public Warrants was all charged to shareholder’s equity upon the completion of the IPO.

Transaction costs amounted

to $26,658,313, consisting of $4,595,000 of underwriting commissions, $11,541,250 of deferred underwriting commissions, $9,680,125 of

excess fair value of founder shares, and $841,938 of other offering costs, with $23,439 allocated to the over-allotment option, $24,538,134

allocated to the Class A ordinary shares subject to redemption, and $2,096,740 allocated to the Class A ordinary shares not subject to

redemption, the Public Warrants and the Private Placement Warrants.

Following the closing

of the IPO on September 24, 2021, $300,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale

of the IPO Private Placement Warrants was deposited into a trust account (the “ Trust Account ”).

Following the closing

of the Over-Allotment on October 29, 2021, an additional $29,750,000 ($10.00 per Over-Allotment Unit) from the net proceeds from the

sale of the Over-Allotment Units in the Over-Allotment and the sale of the Over-Allotment Private Placement Warrants was deposited into

the Trust Account.

The proceeds deposited in the Trust Account are, and will be, invested only in U.S.

government securities, within

the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “ Investment Company Act ”),

having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment

Company Act which invest only in direct U.S.

government treasury obligations.

Except with respect to interest earned on

the funds held in the Trust Account that may be released to the Company to pay taxes, if any, the proceeds from the Public Offering and

the sale of the Private Placement Warrants will not be released from the Trust Account until the earliest of (i) the completion of initial

Business Combination, (ii) the redemption of the Company’s Public Shares if the Company is unable to complete the initial Business

Combination within 24 months from the closing of the IPO, subject to applicable law, or (iii) the redemption of the Company’s Public

Shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles

of association to (A) modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial

Business Combination or to redeem 100% of its Public Shares if the Company has not consummated an initial Business Combination within

24 months from the closing of the IPO or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial

Except with respect to interest earned on the funds held

in the Trust Account that may be released to us to pay taxes, if any, the proceeds from the Public Offering and the sale of the Private

Placement Warrants will not be released from the Trust Account until the earliest of (i) the completion of an initial Business Combination,

(ii) the redemption of our Public Shares if we are unable to complete the initial Business Combination by September 24, 2023, subject

to applicable law, or (iii) the redemption of our Public Shares properly submitted in connection with a shareholder vote to amend our

amended and restated memorandum and articles of association to (A) modify the substance or timing of our obligation to allow redemption

in connection with the initial Business Combination or to redeem 100% of its Public Shares if we have not consummated an initial Business

Combination by September 24, 2023 or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial

Business Combination activity.

The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors,

if any, which could have priority over the claims of the Company’s public shareholders.

The Company’s management has broad discretion

with respect to the specific application of the net proceeds of the Public Offering and the sale of the Private Placement Warrants although

substantially all of the net proceeds are intended to be generally applied toward consummating a Business Combination (less deferred underwriting

commissions).

The Company’s Business Combination must be with one or more operating businesses or assets with a fair market value

equal to at least 80% of the value of the Trust Account (excluding the amount of any deferred underwriting discount held in trust and

taxes payable on the income earned on the Trust Account).

However, the Company will only complete a Business Combination if the post-transaction

company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling

interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940,

as amended, and the rules and regulations promulgated thereunder (the “Investment Company Act”).

There is no assurance

that the Company will be able to successfully effect a Business Combination.

The Company will have 24 months from the closing

of the IPO to complete the initial Business Combination (the “Combination Period”).

However, if the Company is unable to complete

the initial Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding

up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price,

The proceeds deposited in the Trust Account could become subject to the claims of our creditors, if any,

which could have priority over the claims of our Public Shareholders.

Our management has broad

discretion with respect to the specific application of the net proceeds of the Public Offering and the sale of the Private Placement

Warrants although substantially all of the net proceeds are intended to be generally applied toward consummating an initial Business

Combination (less deferred underwriting commissions).

Our initial Business Combination must be with one or more operating businesses

or assets with a fair market value equal to at least 80% of the value of the Trust Account (excluding the amount of any deferred underwriting

discount held in trust and taxes payable on the income earned on the Trust Account).

However, we will only complete an initial Business

Combination if the post-transaction company owns or acquires 50% or more of the issued and outstanding voting securities of the target

or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company

under the Investment Company Act.

There is no assurance that we will be able to successfully effect an initial Business Combination.

We will have until September

24, 2023 to complete the initial Business Combination (the “ Combination Period ”).

However, if we are unable to complete

the initial Business Combination within the Combination Period, we will (i) cease all operations except for the purpose of winding up,

(ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price,

payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the

Trust Account (less tax payable and up to $100,000 of interest to pay dissolution expenses) divided by the number of then outstanding

Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive

further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval

of the Company’s remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in the case

of clauses (ii) and (iii) to the Company’s obligations under Cayman Islands law to provide for claims of creditors and in all cases

subject to the other requirements of applicable law.

Liquidity and Capital Resources

As of September 30, 2021, we had approximately

$0.6 million in cash and working capital of $1.0 million.

On September 30, 2021, the Sponsor agreed to provide

us with loans in such amounts as may be required by us to fund the our working capital requirements up to an aggregate of $250,000 .

In addition, in order to finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our

Sponsor or certain of our officers and directors may, but are not obligated to, provide Working Capital Loans to us.

As of September 30,

2021, there were no amounts outstanding under any Working Capital Loans.

Based on the foregoing, management believes that

the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a

Business Combination or one year from this filing.

Over this time period, the Company will be using these funds for paying existing accounts

payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target

businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating

the Business Combination.

Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to

receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to

the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in the case of clauses (ii) and

(iii) to our obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements

of applicable law.

Liquidity and Capital

Going Concern

As of March 31, 2022, we

had approximately $0.16 million in cash and working capital of $0.38 million.

On September 30, 2021, our Sponsor agreed to provide us with loans

in such amounts as may be required by us to fund our working capital requirements up to an aggregate of $250,000.

March 8, 2022, the Sponsor agreed to provide the Company with loans in such amounts as may be required by the Company to fund the Company’s

working capital requirements up to an aggregate of $500,000.

In addition, in order to finance transaction costs in connection with

an initial Business Combination, our sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not

obligated to, provide Working Capital Loans to us.

As of March 31, 2022, there were no amounts outstanding under any Working Capital Loans.

Based on the foregoing,

it is possible that the approximately $0.16 million in cash held outside the Trust Account might not be sufficient to allow us to operate

for at least 12 months from the date of this Quarterly Report, assuming that an initial Business Combination is not consummated during

Until consummation of its initial Business Combination, we will be using these funds for paying existing accounts payable,

identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses,

paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating

the initial Business Combination.

We can raise additional

capital through Working Capital Loans from our Sponsor, certain of our officers and directors, or through loans from third parties.

we are unable to raise additional capital, we may be required to take additional measures to conserve liquidity, which could include,

but not necessarily be limited to, curtailing operations, suspending the pursuit of our business plan, and reducing overhead expenses.

We cannot provide assurance that new financing will be available to us on commercially acceptable terms, if at all.

These conditions

raise substantial doubt about our ability to continue as a going concern for a reasonable period of time, which is considered to be one

year from the issuance date of the financial statements included elsewhere in this Quarterly Report.

Risks and Uncertainties

Management is currently evaluating the impact

of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s

financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as

of the date of these financial statements.

The financial statements do not include any adjustments that might result from the outcome

of this uncertainty.

Management continues

to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative

effect on our financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable

as of the date of this Quarterly Report.

The financial statements do not include any adjustments that might result from the outcome of

this uncertainty.

Results of Operations

As of September 30,

As of March 31, 2022,

we had not commenced any operations.

All activity for the period from January 27, 2021 (inception) through September 30, 2021 relates

to our formation and the Initial Public Offering and, subsequent to the closing of the IPO, identifying a target company for a

Business Combination .

We have neither engaged in any operations nor generated any revenues

We will not generate any operating revenues until after the completion of our initial

Business Combination, at the earliest.

We will generate non-operating income in the form of interest income on cash

and cash equivalents from the proceeds derived from the IPO and Over-Allotment.

We expect to incur increased expenses as a result

of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the period from January 27, 2021 (inception)

to September 30, 2021, we had net loss of $41,425, which consisted of formation and operating costs amounting to $41,625 offset by interest

income earned on cash and marketable securities held in Trust Account amounting to $200.

For the three months ended September 30, 2021,

we had a net loss of $21,537 which consisted of formation and operating costs amounting to $21,737 offset by interest income earned on

cash and marketable securities held in Trust Account amounting to $200.

Contractual Obligations

We do not have any long-term debt obligations,

capital lease obligations, operating lease obligations, purchase obligations or long-term liabilities.

Administrative Services Agreement

Commencing on September 22, 2021, we agreed to

pay Kingstown Capital Management L.P., an affiliate of the Sponsor, $15,000 per month for office

space, utilities and secretarial and administrative support services.

Upon the earlier of the completion of the initial Business

Combination or our liquidation, we will cease paying such monthly fees.

All activity for the period from January 27, 2021 (inception) through March 31, 2022 relates to

our formation and the Public Offering and, subsequent to the closing of the IPO, identifying a target company for an initial Business

We have neither engaged in any operations nor generated any revenues to date.

We will not generate any operating

revenues until after the completion of our initial Business Combination, at the earliest.

We generate non-operating income in

the form of interest income on cash and cash equivalents from the proceeds derived from the Public Offering.

We incur increased

expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due

diligence expenses.

For the three months

ended March 31, 2022, we had net loss of $320,455, which consisted primarily of formation and operating costs amounting to $347,869 offset

by interest income earned on cash and marketable securities held in Trust Account amounting to $27,414.

For the period from

January 27, 2021 (inception) to March 31, 2021, we had net loss of $16,114, which consisted solely of formation and operating costs.

We do not have any long-term

debt obligations, capital lease obligations, operating lease obligations, purchase obligations or long-term liabilities.

As of March 31, 2022,

we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

Administrative Services

Commencing on September

22, 2021, we agreed to pay Kingstown Capital Management L.P., an affiliate of our Sponsor, $15,000 per month for office space, utilities

and secretarial and administrative support services.

Upon the earlier of the completion of the initial Business Combination or our

liquidation, we will cease paying such monthly fees.

Registration Rights

The holders of the (i) Founder Shares, which

were issued in a private placement prior to the closing of the IPO, (ii) Forward Purchase Shares, (iii) Private Placement Warrants

which were issued in private placements simultaneously with the closing of the IPO and the Over-Allotment and the Class A ordinary

shares underlying such Private Placement Warrants and (iv) warrants that may be issued upon conversion of working capital loans and

the Class A ordinary shares underlying such warrants will have registration rights to require us to register a sale of any of our

securities held by them and any other securities of the Company acquired by them prior to the consummation of our initial Business Combination

pursuant to a registration rights agreement entered into in connection with the IPO.

Pursuant to the registration rights agreement and

assuming $1,500,000 of working capital loans are converted into additional Private Placement Warrants, we will be obligated to register

up to 21,588,750 Class A ordinary shares and 8,345,000 Private Placement Warrants.

The number of Class A ordinary shares includes

(i) 8,243,750 Class A ordinary shares to be issued upon conversion of the Founder Shares, (ii) 5,000,000 Forward Purchase Shares,

(iii) 6,845,000 Class A ordinary shares underlying the Private Placement Warrants and (iv) 1,500,000 Class A ordinary shares

underlying the Private Placement Warrants issuable upon conversion of working capital loans.

The number of warrants includes 6,845,000

Private Placement Warrants and 1,500,000 additional Private Placement Warrants issuable upon the conversion of working capital loans.

The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities.

In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent

to our completion of our initial business combination.

We will bear the expenses incurred in connection with the filing of any such registration

The holders of the (i) Founder

Shares and the Class A ordinary shares issuable upon conversion of Founder Shares, (ii) Forward Purchase Shares, (iii) Private

Placement Warrants and the Class A ordinary shares underlying such Private Placement Warrants and (iv) warrants that may be

issued upon conversion of Working Capital Loans and the Class A ordinary shares underlying such warrants will have registration

rights to require us to register a sale of any of our securities held by them and our any other securities acquired by them prior to

the consummation of our initial Business Combination pursuant to a registration rights agreement entered into in connection with the

Pursuant to the registration rights agreement and assuming $1,500,000 of Working Capital Loans are converted into additional Private

Placement Warrants, we will be obligated to register up to 21,588,750 Class A ordinary shares and 8,345,000 Private Placement Warrants.

The number of Class A ordinary shares includes (i) 8,243,750 Class A ordinary shares to be issued upon conversion of the

Founder Shares, (ii) 5,000,000 Forward Purchase Shares, (iii) 6,845,000 Class A ordinary shares underlying the Private Placement

Warrants and (iv) 1,500,000 Class A ordinary shares underlying the warrants issuable upon conversion of working capital loans.

number of warrants includes 6,845,000 Private Placement Warrants and 1,500,000 additional warrants issuable upon the conversion of Working

Capital Loans.

The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register

such securities.

In addition, the holders have certain “piggy-back” registration rights with respect to registration statements

filed subsequent to our completion of our initial Business Combination.

We will bear the expenses incurred in connection with the filing

of any such registration statements.

Underwriting Agreement

The Company granted the underwriter a 45-day option

from the date of IPO prospectus to purchase up to an additional 4,500,000 units to cover over-allotments, if any.

On October 29, 2021,

the underwriters partially exercised the over-allotment option and purchased 2,975,000 Over-Allotment Units, generating an aggregate of

We granted the underwriters

a 45-day option from the Effective Date to purchase up to an additional 4,500,000 Units to cover over-allotments, if any.

29, 2021, the underwriters partially exercised the over-allotment option and purchased 2,975,000 Over-Allotment Units, generating aggregate

gross proceeds of $29,750,000, and forfeited their option to purchase the remaining 1,525,000 Units.

The underwriters were entitled to a cash underwriting

discount of 2.0% per Unit, or $4,595,000, excluding the proceeds from the purchase of an aggregate of 10,000,000 units by certain of our

anchor investors, $4,000,000 of which was payable upon the closing of the IPO and $595,000 was payable upon closing of the Over-Allotment.

The underwriters were

entitled to a cash underwriting discount of 2.0% per Unit, or $4,595,000, excluding the proceeds from the purchase of an aggregate of

10,000,000 Units by certain of our Anchor Investors, $4,000,000 of which was payable upon the closing of the IPO and $595,000 was payable

upon closing of the Over-Allotment.

Additionally, Citigroup Global Markets Inc.

will be entitled to a deferred underwriting discount

of 3.5% of the gross proceeds of the Public Offering, or $11,541,250 upon the completion of the Company’s initial Business Combination.

The deferred fee will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company

completes a Business Combination, subject to the terms of the underwriting agreement.

Critical Accounting Policies

will be entitled to a deferred underwriting

discount of 3.5% of the gross proceeds of the Public Offering, or $11,541,250 upon the completion of our initial Business Combination.

The deferred fee will become payable from the amounts held in the Trust Account solely in the event that we complete an initial Business

Combination, subject to the terms of the underwriting agreement.

Professional Service

We reimburse our Sponsor

for services provided by one of our Sponsor’s employees who serves as our Chief of Staff (“ COS ”).

The COS receives

$12,500 per month for services rendered, commencing September 25, 2021, through the closing of our initial Business Combination.

the three months ended March 31, 2022, we recorded $37,500 of compensation for services provided.

As of March 31, 2022, there was no

balance due to the COS.

Critical Accounting

This management’s

discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared

in accordance with US GAAP.

The preparation of our financial statements requires us to make estimates and judgments that affect the reported

amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our financial statements.

On an ongoing basis, we evaluate our estimates and judgments, including those related to fair value of financial instruments and accrued

We base our estimates on historical experience, known trends and events and various other factors that we believe to be reasonable

under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities

that are not readily apparent from other sources.

Actual results may differ from these estimates under different assumptions or conditions.

We have identified the following as its critical accounting policies:

Offering Costs

with the requirements of the ASC 340-10-S99-1.

Offering costs consists of legal, accounting, underwriting fees and other costs incurred

through the balance sheet date that are directly related to the Public Offering.

Offering costs are allocated to the separable financial

instruments to be issued in the IPO based on a relative fair value basis, compared to total proceeds received.

Upon closing of the

IPO on September 24, 2021, transaction costs amounted to $15,271,938 consisting of $4,000,000 of underwriting commissions, $10,500,000

of deferred underwriting commissions, and $771,938 of other offering costs, and was all charged to shareholders’ equity.

Class A Ordinary Share Subject to Possible

We comply with the requirements

of the ASC 340-10-S99-1.

Offering costs consists of legal, accounting, underwriting fees and other costs incurred through the balance

sheet date that are directly related to the Public Offering.

Offering costs are allocated to the separable financial instruments

to be issued in the Public Offering based on a relative fair value basis, compared to total proceeds received.

Transaction costs

amounted to $26,658,313, consisting of $4,595,000 of underwriting commissions, $11,541,250 of deferred underwriting commissions, $9,680,125

of excess fair value of founder shares, and $841,938 of other offering costs, with $23,439 included in the statement of operations as

an allocation for the over-allotment option, $24,538,134 included in temporary equity as an allocation for the Class A ordinary shares

subject to redemption, and $2,096,740 included in additional paid-in capital as an allocation for the Class A ordinary shares not subject

to redemption, the Public Warrants and the Private Placement Warrants.

Subject to each Anchor

Investor purchasing 100% of the Units allocated to it in the IPO, and in connection with the closing of the IPO, our Sponsor sold membership

interests reflecting an allocation of an aggregate of 1,625,000 Founder Shares to the Anchor Investors collectively.

We, through an independent

valuations expert, estimated the aggregate fair value of these Founder Shares attributable to Anchor Investors to be approximately $9.68

million, or $5.96 per share.

The excess of the fair value of the Founder Shares was determined to be an offering cost in accordance with

Staff Accounting Bulletin Topic 5A.

Class A Ordinary

Shares Subject to Possible Redemption

All of the Class A Ordinary

Share sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such Public Shares

in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination

and in connection with certain amendments to the Company’s amended and restated memorandum and articles of association.

In accordance

with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions

not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity.

in connection with our liquidation, if there is a shareholder vote or tender offer in connection with the initial Business Combination

and in connection with certain amendments to our amended and restated memorandum and articles of association.

In accordance with SEC

and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not

solely within our control require ordinary shares subject to redemption to be classified outside of permanent equity.

The Class A ordinary

shares are subject to SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99.

If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption

value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable,

if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur

and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period.

The Company recognizes

changes in redemption value immediately as they occur.

Immediately upon the closing of the IPO, the Company recognized the accretion from

If it is probable that the equity instrument will become redeemable, we have the option to either accrete changes in the redemption value

over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later)

to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust

the carrying amount of the instrument to equal the redemption value at the end of each reporting period.

We recognize changes in redemption

value immediately as they occur.

Immediately upon the closing of the IPO and the Over-Allotment, we recognized the remeasurement from

initial book value to redemption amount value.

The change in the carrying value of redeemable ordinary share resulted in charges against

additional paid-in capital and accumulated deficit.

Related Party Redemption Waiver Agreement

In September 2021, the Company entered into a

redemption waiver agreement with one of its anchor investors, Kingstown 1740 Fund, LP, whereby Kingstown 1740 Fund, LP agreed to waive

its redemption rights on 1,386,989 Class A ordinary shares it holds, and these ordinary shares are classified as shareholders’ equity.

Net Loss Per Ordinary Share

has two classes of shares, Class A ordinary shares and Class B ordinary shares.

Earnings and losses are shared pro rata between the two

classes of shares.

The Company has not considered the effect of the warrants sold in the Public Offering or the Private Placement Warrants

to purchase an aggregate of 21,250,000 of the Company’s Class A ordinary shares in the calculation of diluted income per share,

since their exercise is contingent upon future events .

Nor has the Company included

the 1,125,000 Class B shares that were subject to forfeiture at September 30, 2021 in calculation of diluted income per shares.

As a result, diluted net loss per

ordinary share is the same as basic net loss per ordinary share for the periods.

Off-Balance Sheet Arrangements

As of September 30, 2021, we did not have any

off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

We do not believe that inflation had a material

impact on our business, revenues or operating results during the period presented.

Emerging Growth Company Status

We are an “emerging growth company,”

as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS

Act”), and may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies

that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements

of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports

and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder

approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act

exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies

(that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered

under the Exchange Act) are required to comply with the new or revised financial accounting standards.

The JOBS Act provides that a company

can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies

but any such election to opt out is irrevocable.

We have elected not to opt out of such extended transition period which means that when

a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth

company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make comparison

of our financial statements with another public company which is neither an emerging growth company nor an emerging growth company which

has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards

Quantitative and Qualitative Disclosures About Market Risk.

The change in the carrying value of redeemable ordinary shares resulted in charges against

additional paid-in capital.

Related Party Redemption

Waiver Agreement

In September 2021, we

entered into a redemption waiver agreement with one of our Anchor Investors, Kingstown 1740 Fund, LP, whereby Kingstown 1740 Fund, LP

agreed to waive its redemption rights on 1,386,989 Class A ordinary shares it holds, and these Class A ordinary shares are classified

as shareholders’ equity.

Net Loss Per Ordinary

We comply with accounting

and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Our statement of operations includes a presentation of

income per share for ordinary shares subject to possible redemption in a manner similar to the two-class method of income per share.

The remeasurement associated with the redeemable Class A ordinary shares is excluded from net loss per ordinary share as the redemption

value approximates fair value.

Net income per share, basic and diluted, for Class A redeemable ordinary shares is calculated by dividing

interest income earned and realized gains or losses on the Trust Account for the three months ended March 31, 2022 and for the period

from January 27, 2021 (Inception) to March 31, 2021, by the weighted average number of Class A redeemable ordinary shares outstanding

since original issuance.

We have not considered the effect of the Public Warrants or the Private Placement Warrants to purchase an aggregate

of 23,332,500 of our Class A ordinary shares in the calculation of diluted income per share, since their exercise is contingent

upon future events.

Net income per share, basic and diluted, for Class A and Class B non-redeemable ordinary shares is calculated by

dividing the net income, adjusted for income or loss attributable to Class A redeemable ordinary shares, by the weighted average number

of Class A and Class B non-redeemable ordinary shares outstanding for the period.

Class A and Class B non-redeemable ordinary shares

includes the Founder Shares as these shares do not have any redemption features and do not participate in the income or losses of the

Trust Account.

At March 31, 2022, we did not have any dilutive securities and other contracts that could, potentially, be exercised or

converted into ordinary shares and then share in the earnings of our company.

As a result, diluted income per share is the same as basic

income per share for the period presented.

We evaluated the warrants

in accordance with ASC 815-40, “Derivatives and Hedging — Contracts in Entity’s Own Equity,” and concluded that

there were no indexation or tender offer provisions in the warrant agreement that precluded the warrants from being accounted for as

components of equity, and the warrants meet the criteria in ASC 815-40-25 to be classified in shareholders’ equity.

of the Public and Private Placement Warrants was determined by an independent valuation expert as of September 24, 2021 (the date of

the IPO) and October 29, 2021 (the date of the Over-Allotment) using a Monte Carlo Model.

Proceeds from the IPO and subsequent partial

exercise of the over-allotment option allocated to the Public Warrants was an aggregate $11,995,753 ($11,025,229, net of offering costs)

and is recorded in additional paid-in capital.

Proceeds from the issuance of the Private Placement Warrants were $6,845,000 ($6,831,701,

net of offering costs) and is recorded in additional paid-in capital.

Forward Purchase

In September 2021, we

entered into a forward purchase agreement (“ FPA ”) pursuant to which certain affiliates of our Sponsor (“ Kingstown ”)

agreed to purchase up to 5,000,000 forward purchase Class A ordinary shares (“ Forward Purchase Shares ”), for $10.00

per share, or an aggregate amount of up to $50,000,000, in a private placement that will close concurrently with the closing of our initial

Business Combination, subject to approval by the Kingstown investment committee.

We have the right, in our sole discretion, to reduce

the amount of Forward Purchase Shares that Kingstown may purchase pursuant to the FPA.

We have not considered the effect of the Forward

Purchase Shares in the calculation of diluted income per share, since their issuance is contingent upon future events.

We evaluated the FPA

under ASC 480 and ASC 815-40 to determine the appropriate accounting treatment.

The FPA does not meet the criteria to be classified as

a liability under ASC 480.

In addition, there is no net cash settlement feature and settlement will be in gross physical delivery of

Class A ordinary shares;

therefore, the FPA should be classified as equity.

However, as the issuance of Forward Purchase Shares is contingent

on several factors, including the consummation of the initial Business Combination, approval by the Kingstown investment committee, and

our discretion, we will record the FPA when it becomes probable that the triggering events will occur.

Until such time, due to the contingent

nature of the FPA, we will disclose the contingency in the notes to our financial statements.

We do not believe that

inflation had a material impact on our business, revenues or operating results during the period presented.

Emerging Growth Company

We are an “emerging

growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act

of 2012, (the “ JOBS Act ”), and may take advantage of certain exemptions from various reporting requirements that are

applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply

with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive

compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote

on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1)

of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until

private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class

of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards.

Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth

companies but any such election to opt out is irrevocable.

We have elected not to opt out of such extended transition period which means

that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging

growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make

comparison of our financial statements with another public company which is either not an emerging growth company or an emerging growth

company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting

standards used.

Quantitative and Qualitative Disclosures

About Market Risk.

We are a smaller reporting company as defined

1 unchanged sentence

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 2. Management’s Discussion and Analysis